Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis.

Winckers K, Ten Cate-Hoek AJ, Beekers KC, Erkens P, Hamulyák K, Ten Cate H, Hackeng TM.

J Thromb Haemost. 2012 Oct;10(10):2208-11. doi: 10.1111/j.1538-7836.2012.04884.x. No abstract available.

2.

Abnormal Protac-induced coagulation inhibition chromogenic assay results are associated with an increased risk of recurrent venous thromboembolism.

Tripodi A, Legnani C, Lemma L, Cosmi B, Palareti G, Chantarangkul V, Mannucci PM.

J Thromb Thrombolysis. 2010 Aug;30(2):215-9. doi: 10.1007/s11239-010-0479-z.

PMID:
20419336
3.

Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.

Cosmi B, Legnani C, Iorio A, Pengo V, Ghirarduzzi A, Testa S, Poli D, Tripodi A, Palareti G; PROLONG Investigators (on behalf of FCSA, Italian Federation of Anticoagulation Clinics)..

Eur J Vasc Endovasc Surg. 2010 Mar;39(3):356-65. doi: 10.1016/j.ejvs.2009.11.022. Epub 2010 Jan 19.

4.

Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.

Sonnevi K, Tchaikovski SN, Holmström M, Rosing J, Bremme K, Lärfars G.

Thromb Haemost. 2011 Nov;106(5):901-7. doi: 10.1160/TH11-04-0254. Epub 2011 Sep 22.

PMID:
21947267
5.

Total tissue factor pathway inhibitor and venous thrombosis. The Longitudinal Investigation of Thromboembolism Etiology.

Zakai NA, Lutsey PL, Folsom AR, Heckbert SR, Cushman M.

Thromb Haemost. 2010 Aug;104(2):207-12. doi: 10.1160/TH09-10-0693. Epub 2010 Apr 29.

6.

Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.

Donadini MP, Ageno W, Antonucci E, Cosmi B, Kovacs MJ, Le Gal G, Ockelford P, Poli D, Prandoni P, Rodger M, Saccullo G, Siragusa S, Young L, Bonzini M, Caprioli M, Dentali F, Iorio A, Douketis JD.

Thromb Haemost. 2014 Jan;111(1):172-9. doi: 10.1160/TH13-04-0336. Epub 2013 Oct 24.

PMID:
24154729
7.

Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.

Prandoni P, Barbar S, Milan M, Campello E, Spiezia L, Piovella C, Pesavento R.

Thromb Haemost. 2015 Jun;113(6):1210-5. doi: 10.1160/TH14-04-0396. Epub 2014 Aug 14. Review.

PMID:
25119194
8.
9.

Predicting the risk of recurrent venous thromboembolism. The Austrian study on recurrent venous thromboembolism (AUREC).

Kyrle PA, Eischer L.

Hamostaseologie. 2013 Aug 1;33(3):201-9. doi: 10.5482/HAMO-13-03-0018. Epub 2013 May 27.

PMID:
23712242
10.

Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation.

Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA.

JAMA. 2006 Jul 26;296(4):397-402.

PMID:
16868297
11.

Thrombin generation as an intermediate phenotype for venous thrombosis.

Segers O, van Oerle Rv, ten Cate Ht, Rosing J, Castoldi E.

Thromb Haemost. 2010 Jan;103(1):114-22. doi: 10.1160/TH09-06-0356. Epub 2009 Nov 13.

PMID:
20062924
12.

Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.

Tchaikovski SN, Thomassen MC, Costa SD, Peeters LL, Rosing J.

Thromb Haemost. 2011 Nov;106(5):914-21. doi: 10.1160/TH11-04-0244. Epub 2011 Oct 6.

PMID:
21979881
13.

Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.

van Hylckama Vlieg A, Christiansen SC, Luddington R, Cannegieter SC, Rosendaal FR, Baglin TP.

Br J Haematol. 2007 Sep;138(6):769-74.

PMID:
17760809
14.

Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.

Douketis J, Tosetto A, Marcucci M, Baglin T, Cushman M, Eichinger S, Palareti G, Poli D, Tait RC, Iorio A.

Ann Intern Med. 2010 Oct 19;153(8):523-31. doi: 10.7326/0003-4819-153-8-201010190-00009. Review.

PMID:
20956709
15.

Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies.

Galanaud JP, Bosson JL, Genty C, Presles E, Cucherat M, Sevestre MA, Quere I, Decousus H, Leizorovicz A.

J Thromb Haemost. 2012 Jun;10(6):1004-11. doi: 10.1111/j.1538-7836.2012.04704.x.

16.

Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism.

Prandoni P, Lensing AW, Prins MH, Bernardi E, Marchiori A, Bagatella P, Frulla M, Mosena L, Tormene D, Piccioli A, Simioni P, Girolami A.

Ann Intern Med. 2002 Dec 17;137(12):955-60.

PMID:
12484710
17.

Monocyte count and procoagulant functions are associated with risk of venous thromboembolism: the Tromsø study.

Basavaraj MG, Brækkan SK, Brodin E, Østerud B, Hansen JB.

J Thromb Haemost. 2011 Aug;9(8):1673-6. doi: 10.1111/j.1538-7836.2011.04411.x. No abstract available.

18.

Exclusion of first-episode deep-vein thrombosis after-hours using D-dimer.

Rathbun SW, Whitsett TL, Raskob GE.

Blood Coagul Fibrinolysis. 2007 Dec;18(8):795-800.

PMID:
17982322
19.

Factor IX activity/antigen ratio and the risk of first unprovoked venous thromboembolism.

Campello E, Spiezia L, Bulato C, Gavasso S, Woodhams B, Simioni P.

Thromb Haemost. 2013 Apr;109(4):755-6. doi: 10.1160/TH12-12-0954. Epub 2013 Feb 28. No abstract available.

PMID:
23446552
20.

The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study.

van Hylckama Vlieg A, Baglin CA, Luddington R, MacDonald S, Rosendaal FR, Baglin TP.

J Thromb Haemost. 2015 Sep;13(9):1642-52. doi: 10.1111/jth.13043. Epub 2015 Aug 27.

PMID:
26178257

Supplemental Content

Support Center